TABLE 3:
Lesion type on MR image in patients before (group 0) and after kidney transplant (groups 1–3)
| Group(s)* | Normal | Acute Changes |
Chronic Changes |
||||||
|---|---|---|---|---|---|---|---|---|---|
| AI | I | PRES | LI | MA | T | Dura | C | ||
| 0 | 8 (33) | 2 (8) | 0 | 1 (4) | 3 (13) | 10 (42) | 0 | 0 | 0 |
| 1 | 4 (21) | 3 (16) | 2 (11) | 1 (5) | 4 (21) | 6 (32) | 0 | 1 (5) | 1 (5) |
| 2 | 7 (32) | 2 (9) | 0 | 1 (5) | 7 (32) | 10 (45) | 0 | 1 (5) | 2 (9) |
| 3 | 12 (33) | 4 (11) | 3 (8) | 2 (6) | 6 (17) | 13 (33) | 1 (3) | 2 (6) | 3 (8) |
| 1–3 | 23 (30) | 9 (12) | 5 (6) | 4 (5) | 17 (22) | 29 (38) | 1 (1) | 4 (5) | 6 (8) |
Note.—Number of patients is followed by percentage in parentheses. AI indicates acute and subacute infarct; I, infection; PRES, posterior reversible encephalopathy syndrome; LI, chronic lacunar infarct; MA, microangiopathy; T, tumor; Dura, dural thickening; C, thickened calvaria.
*
Group 0 (no. patients/no. MR imaging examinations), 24/26; group 1, 19/21; group 2, 22/26; group 3, 36/51.